Session 126 - CROI 2009

Session 126 Poster Abstracts
Subclinical Atherosclerosis and Cardiovascular Events: Role of HIV and ART
Tuesday, 1-2:30 pm
Poster Hall

721	No Association of Abacavir Use with Risk of Myocardial Infarction or Severe Cardiovascular Disease Events: Results from ACTG A5001 Constance Benson*¹, H Ribaudo², E Zheng², S Koletar³, M Smurzynski², R Bosch², B Bastow⁴, A Collier⁵, J Schouten⁵, and the ACTG A5001/ALLRT Protocol Team ¹Univ of California, San Diego Sch of Med, US; ²Harvard Sch of Publ Hlth, Boston, MA, US; ³Ohio State Univ Coll of Med, Columbus, US; ⁴Social & Sci Systems Inc, Silver Spring, MD, US; and ⁵Univ of Washington Sch of Med, Seattle, US
722	Endothelial Function, Lipoproteins,and Cardiovascular Inflammatory Markers in Treated HIV-infected Patients with Hyperlipidemia Who Were Switched to an Atazanavir-containing Regimen or Continued on Other Protease Inhibitor-based Therapy: Switch to Atazanavir and Brachial Artery Reactivity Study Robert Murphy*¹, C Zala², B Berzins¹, C Fichtenbaum³, M Dube⁴, G Guaraldi⁵, F Torriani⁶, E Belsey⁷, C Mitchell⁸, J Stein⁸, and SABAR Study Team ¹Northwestern Univ, Chicago, IL, US; ²ACLIRES-Argentina, Buenos Aires; ³University of Cincinnati College of Medicine, Cincinnati, OH, US; ⁴Univ of Southern California, Los Angeles, US; ⁵Univ of Modena and Reggio Emilia, Italy; ⁶Univ of California, San Diego, US; ⁷SigmaClinical, Daglan, France; and ⁸University of Wisconsin, Madison, WI, US
723	Association of Abacavir and HIV Disease Factors with Endothelial Function in Patients on Long-term Suppressive ART P Hsue, Y Wu, A Schnell, P Ganz, P Hunt, H Hatano, J Martin, and Steven Deeks* San Francisco Gen Hosp, Univ of California, San Francisco, US
724	HIV Infection Is Independently Associated with Detectable Coronary Artery Calcium Priscilla Hsue*, S Deeks, A Schnell, M Krone, Y Xie, T Lee, K Ordovas, G Reddy, P Ganz, and J Martin San Francisco Gen Hosp, Univ of California, San Francisco, US
725	Untreated HIV Infection Is Associated with Imparied Arterial Elasticity Jason Baker*^1,2, D Duprez¹, J Rapkin¹, R Grimm^1,2, J Neaton¹, and K Henry^1,2 ¹Univ of Minnesota, Minneapolis, US and ²Hennepin County Med Ctr, Minneapolis, MN, US
726	Framingham Risk Score and Markers of Early Atherosclerosis in a Cohort of HIV-infected Subjects Liana Falcone*¹, A Mangili^1,2, S Skinner², J Polak¹, and C Wanke^1,2 ¹Tufts Med Ctr, Boston, MA, US and ²Tufts Univ Sch of Med, Boston, MA, US
727	The Role of Immune Reconstitution in the Onset of Subclinical Atheromasic Lesions Paolo Maggi*¹, F Perilli², A Lillo², A Volpe¹, C Bellacosa¹, G Pastore¹, and G Regina² ¹Clinica delle Malattie Infettive - Università degli Studi di Bari and ²Cattedra di Chirurgia Vascolare - Università degli Studi di Bari
728	Endothelial Fibrinolytic Capacity Is Impaired in HIV-1-infected Men Michael Mestek*, B Stauffer, C Westby, B Weil, G Van Guilder, J Greiner, E Connick, and C Desouza Univ of Colorado, Boulder and Denver, US
729	The in vitro Effects of HIV Proteins, Inflammatory Mediators, HIV-infected T Cells, and Pentoxifylline on Endothelial Cell Inflammation M Clauss¹, Y Zhang¹, G Rajashekhar¹, J Rehman², I-W Park¹, J He¹, and Samir Gupta*¹ ¹Indiana Univ Sch of Med, Indianapolis, US and ²Univ of Chicago, Pritzker Sch of Med, IL, US
730	Longitudinal Evaluation of Pulmonary Artery Pressures in HIV Infection Jennifer Ho*, H Farah, A Bolger, C Kalapus, A Schnell, S Deeks, J Martin, and P Hsue Univ of California, San Francisco, US
731	HIV-1 Infection Is Associated with Accelerated Vascular Aging Gary Van Guilder*, B Stauffer, M Mestek, C Westby, J Greiner, E Connick, and C Desouza Univ of Colorado, Boulder and Denver, US